Janssen Pharmaceutical K.k.

This phase 2 study tests whether a combination of two hormone-blocking drugs (apalutamide and a GnRH agonist) can shrink or slow advanced salivary gland cancers that have a specific protein called the androgen receptor. About 31 adults with locally advanced or spread salivary gla…

This study tests a gene therapy for Japanese people with X-linked retinitis pigmentosa, a genetic condition that causes gradual vision loss. The treatment delivers a working gene to the retina using a harmless virus. The main goals are to check safety and see if it can slow or im…

This study tests a new drug called teclistamab in about 40 Japanese patients whose multiple myeloma has come back or stopped responding to other treatments. The drug is a special antibody that helps the immune system attack cancer cells. The goal is to see if it is safe and how w…